The pharmaceutical industry is bracing for potential disruption from President Trump’s drug pricing policies and tariffs, which could impact research and development investments. According to a recent report, Eli Lilly, Johnson & Johnson, and AbbVie have invested more in the US after decades of decline. The Pharmaceutical Research and Manufacturers of America (PhRMA) argues that tariffs would harm American manufacturing and hinder the development of future treatments.
President Trump has threatened to impose up to 200% tariffs on pharmaceuticals, but suggested a delay of around one-and-a-half years for companies to adjust. However, the industry remains opposed to this proposal, citing concerns over increased costs and potential shortages.
Economist Intelligence: EIU
@TheEIU
·
6h The pharmaceutical sector is facing mounting uncertainty due to US tariffs. Pharma firms face a shifting landscape. Discover the implications for global supply chains and pricing in EIU’s latest report: http://econgrp.co/W9
#Pharma #Tariffs #GlobalTrade
FiscalNote
@FiscalNote
·
Jul 2 In a recent
@FiscalNote
survey of experts across 18 industries, 57 percent say #tariffs are now a high or top concern.
But most teams are stuck in wait-and-see mode, watching as trade policies shift under their feet. https://fnlink.co/45rV7Z8
CJ Warnke
@cjwarnke
·
4h NEW from
@axios
: Many companies are already feeling tariff pain.
57% of companies were already experiencing a tariff-driven decline in gross margins as of May
77% of respondents said their companies are considering price increases of at least 5% in the next six months.
Mike Waugh
@tradewartracker
·
Jul 7 Another timely one.
How do changes in trade frictions (like tariffs) affect inflation?
by
@RichRHC
and a team from
@federalreserve
Key finding is that when the tariff hits intermediate goods (which is 40 percent of U.S. imports), inflation is more persistent.
aPriori
@aPriori_Inc
·
Jul 8 Manufacturers, are you still reeling from the unexpected challenges of tariffs, even after navigating the pandemic?
You’re not alone.
While COVID-19 taught valuable operational lessons, tariffs present a fundamentally different challenge—economic barriers impacting cost
Economist Intelligence: EIU
@TheEIU
·
Jul 3 As the threat of US tariffs increases, automakers in the UK, Japan, and the EU are adapting operations to mitigate supply chain risk. To understand the trade disruptions impacting the automotive sector, download EIU’s latest report: http://econgrp.co/VV
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
